The first IAM Global Leaders publication runs interviews with internationally-respected practitioners who, among other things, talk the future, the past, deal-making, practice management and how to meet changing client demands
Move by Parallax Health Sciences is an indication that patent assertion plays could increasingly affect life sciences companies as their use of digital technologies increases
Read more
Viex Capital calls for appointment of five new directors citing failure to implement credible business plan, irresponsible governance and value destroying compensation practices
Read more
Nineteen companies in all took the chance to secure rights to the portfolio before a contingent of South Korean and Japanese patent owners departed the pool last Thursday
Read more
Intellectual property systems are becoming more complex and that makes law schools’ one-size-fits all approach looks increasingly out of date, says Franklin Pierce dean
Read more
A big year for Apple and Qualcomm; change at the top at Nokia, Ericsson and Microsoft; Huawei under the spotlight; and more from the past 12 months
Read more
After deal for cellular chip business with Apple, the company places rest of the assets that were on the market in the summer back on the auction block
Read more
IAM is currently seeking nominations for individuals to be considered for the 2020 edition of the Strategy 300 - our unique guide to the men and women who excel in the creation of IP value
Read more
The California case was one of the early patent battles over the breakthrough cancer cell therapy technology, which is set to become a crowded space in years to come.
Read more
In an exclusive interview, Adam Stoten, the of COO Oxford University Innovation - one of Europe’s largest tech transfer offices - explains the challenges of protecting and commercialising early-stage life sciences inventions
Read more
Why Qualcomm’s winning of an injunction in China against Apple is another sign that the patent market is drifting inexorably eastwards. With the country’s answer to the Court of Appeals for the Federal Circuit opening at the start of this year, rights holders have even more reason to turn to Chinese courts.
Read more
The USPTO director’s explicit rejection of the ‘troll’ narrative and the departure of key Congressional backers mean that big technology companies find themselves in the unusual position of not being in control of the US IP policy-making narrative.
Read more
@IAM_magazine RT @WTRmagazine: Article updated: The USPTO is to re-allow PO boxes on trademark applications following privacy backlash. The USPTO has now… Read more
We use cookies on www.iam-media.com. By using this site, you agree that we may store and access cookies on your device. For further information please read our cookie policy and our terms and conditions.
